Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2014, Article ID 170626, 4 pages
http://dx.doi.org/10.1155/2014/170626
Research Article

Gamma-Glutamyl Transferase Levels in Patients with Acute Ischemic Stroke

Department of Neurology, FSM Teaching and Research Hospital, E-5 Uzeri, Bostanci, 34744 Istanbul, Turkey

Received 19 June 2014; Revised 4 August 2014; Accepted 8 August 2014; Published 18 August 2014

Academic Editor: Janusz K. Rybakowski

Copyright © 2014 Nurbanu Gurbuzer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Whitfield, “Gamma glutamyl transferase,” Critical Reviews in Clinical Laboratory Sciences, vol. 38, no. 4, pp. 263–355, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. B. W. Karlson, O. Wiklund, P. Hallgren, M. Sjölin, J. Lindqvist, and J. Herlitz, “Ten-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia,” Journal of Internal Medicine, vol. 247, no. 4, pp. 449–456, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Kim, J. J. Noh, N. H. Cho et al., “Serum γ-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors,” Diabetic Medicine, vol. 22, no. 9, pp. 1134–1140, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Shimizu, H. Imano, T. Ohira et al., “γ-glutamyltranspeptidase and incident stroke among japanese men and women: the circulatory risk in communities study (CIRCS),” Stroke, vol. 41, no. 2, pp. 385–388, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Lee, R. Blomhoff, and D. R. Jacobs Jr., “Is serum gamma glutamyltransferase a marker of oxidative stress?” Free Radical Research, vol. 38, no. 6, pp. 535–539, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Paolicchi, G. Minotti, P. Tonarelli et al., “γ-Glutamyl transpeptidase-dependent iron reduction and LDL oxidation: a potential mechanism in atherosclerosis,” Journal of Investigative Medicine, vol. 47, no. 3, pp. 151–160, 1999. View at Google Scholar · View at Scopus
  7. J. Yamada, H. Tomiyama, M. Yambe et al., “Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome,” Atherosclerosis, vol. 189, no. 1, pp. 198–205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Ikai, R. Honda, and Y. Yamada, “Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: A possible pathogenetic role of fatty liver in obesity-related hypertension,” Journal of Human Hypertension, vol. 8, no. 2, pp. 95–100, 1994. View at Google Scholar · View at Scopus
  9. Y. Yamada, E. Ikai, I. Tsuritani, M. Ishizaki, R. Honda, and M. Ishida, “The relationship between serum γ-glutamyl transpeptidase levels and hypertension: common in drinkers and nondrinkers,” Hypertension Research, vol. 18, no. 4, pp. 295–301, 1995. View at Google Scholar · View at Scopus
  10. P. Jousilathi, E. Vartiainen, H. Alho, K. Poikolainen, and P. Sillanaukee, “Opposite association of carbohydrate deficient transferrin and gama-glutamyltransferase with prevalent coronary heart disease,” Archives of Internal Medicine, vol. 162, no. 7, pp. 295–301, 2002. View at Google Scholar
  11. I. J. Perry, S. G. Wannamethee, and A. G. Shaper, “Prospective study of serum γ-glutamyltransferase and risk of NIDDM,” Diabetes Care, vol. 21, no. 5, pp. 732–737, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Nakanishi, K. Nishina, W. Li, M. Sato, K. Suzuki, and K. Tatara, “Serum γ-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men,” Journal of Internal Medicine, vol. 254, no. 3, pp. 287–295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Ruttmann, L. J. Brant, H. Concin, G. Diem, K. Rapp, and H. Ulmer, “γ-glutamyltransferase as a risk factor for cardiovascular disease mortality: An epidemiological investigation in a cohort of 163 944 Austrian adults,” Circulation, vol. 112, no. 14, pp. 2130–2137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. D. H. Lee, D. R. Jacobs, M. Gross et al., “γ-Glutamyltransferase is a predictor of incident diabetes and hypertension: the coronary artery risk development in young adults (CARDIA) study,” Clinical Chemistry, vol. 49, no. 8, pp. 1358–1366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. D. D'Ambrosio, G. Gargiulo, D. Della-Morte et al., “Gamma-glutamyltransferase predicts functional impairment in elderly adults after ischemic stroke,” Journal of the American Geriatrics Society, vol. 61, no. 6, pp. 1040–1041, 2013. View at Google Scholar
  16. P. Korantzopoulos, P. Tzimas, K. Kalantzi et al., “Association between serum gamma-glutamyltransferase and acute ischemic non-embolic stroke in elderly subjects,” Archives of Medical Research, vol. 40, no. 7, pp. 582–589, 2009. View at Google Scholar
  17. D. H. Lee, M. H. Ha, J. H. Kim et al., “Gamma-glutamyltransferase and diabetes—a 4 year follow-up study,” Diabetologia, vol. 46, no. 3, pp. 359–364, 2003. View at Google Scholar · View at Scopus
  18. M. Emdin, A. Pompella, and A. Paolicchi, “Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque,” Circulation, vol. 112, no. 14, pp. 2078–2080, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Brenner, D. Rothenbacher, V. Arndt, S. Schuberth, E. Fraisse, and T. M. Fliedner, “Distribution, determinants, and prognostic value of γ-glutamyltransferase for all-cause mortality in a cohort of construction workers from Southern Germany,” Preventive Medicine, vol. 26, no. 3, pp. 305–310, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Pompella, M. Emdin, C. Passino, and A. Paolicchi, “The significance of serum gamma-glutamyltransferase in cardiovascular diseases,” Clinical Chemistry and Laboratory Medicine, vol. 42, no. 10, pp. 1085–1091, 2004. View at Google Scholar
  21. M. Emdin, C. Passino, L. Donato, A. Paolicchi, and A. Pompella, “Serum γ-glutamyltransferase as a risk factor of ischemic stroke might be independent of alcohol consumption,” Stroke, vol. 33, no. 4, pp. 1163–1164, 2002. View at Publisher · View at Google Scholar · View at Scopus